Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Publication
, Journal Article
Roe, MT; Sapp, SK; Lincoff, AM
Published in: Cleve Clin J Med
February 2000
Glycoprotein (GP) IIb/IIIa inhibitors are potent antiplatelet agents and represent an exciting breakthrough in the treatment of acute coronary syndromes. However, their safety and cost-effectiveness require further investigation, and more information on risk stratification is needed to clarify which patients benefit the most from empiric use of these agents.
Duke Scholars
Published In
Cleve Clin J Med
DOI
ISSN
0891-1150
Publication Date
February 2000
Volume
67
Issue
2
Start / End Page
131 / 140
Location
United States
Related Subject Headings
- Tyrosine
- Tirofiban
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Peptides
- Myocardial Infarction
- Immunoglobulin Fab Fragments
- Humans
- Heparin
- General & Internal Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Roe, M. T., Sapp, S. K., & Lincoff, A. M. (2000). Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Cleve Clin J Med, 67(2), 131–140. https://doi.org/10.3949/ccjm.67.2.131
Roe, M. T., S. K. Sapp, and A. M. Lincoff. “Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.” Cleve Clin J Med 67, no. 2 (February 2000): 131–40. https://doi.org/10.3949/ccjm.67.2.131.
Roe MT, Sapp SK, Lincoff AM. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Cleve Clin J Med. 2000 Feb;67(2):131–40.
Roe, M. T., et al. “Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.” Cleve Clin J Med, vol. 67, no. 2, Feb. 2000, pp. 131–40. Pubmed, doi:10.3949/ccjm.67.2.131.
Roe MT, Sapp SK, Lincoff AM. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Cleve Clin J Med. 2000 Feb;67(2):131–140.
Published In
Cleve Clin J Med
DOI
ISSN
0891-1150
Publication Date
February 2000
Volume
67
Issue
2
Start / End Page
131 / 140
Location
United States
Related Subject Headings
- Tyrosine
- Tirofiban
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Peptides
- Myocardial Infarction
- Immunoglobulin Fab Fragments
- Humans
- Heparin
- General & Internal Medicine